Acino
Alla Sorokoletova has extensive work experience in the field of medical and regulatory affairs, as well as pharmacovigilance and quality assurance. Alla has held various leadership positions in multiple companies. From 2020 onwards, they have been the Director of Medical and Regulatory Affairs, PV, QA Ukraine&CIS and Global Medical Affairs at ACINO. Prior to this, they served as the Head of Global RA, MA, PV at Acino Group from 2018 to 2020. From 2015 to 2020, they worked as the Director of Medical and Regulatory Affairs, PV Department Ukraine & CIS at Acino Pharma AG, Pharma Start LLC. Additionally, they had a role as the Director of Medical and Regulatory Affairs Department, PV of Takeda Company in Ukraine and Moldova from 2012 to 2015 at Takeda Ukraine. Before that, they served as the Head of Medical, RA and PV/QA department at Nycomed Ukraine from 2007 to 2012. Alla started their career as a Medical and RA Manager at the Rep. office of Nycomed in Ukraine from 2003 to 2007.
Alla Sorokoletova obtained a Doctor of Medicine (M.D.) degree in Pediatrics from the National O.O. Bogomolets Medical University in Kiev, Ukraine, from 1997 to 2003. Alla further pursued a Doctor of Philosophy (Ph.D.) in Pediatrics from the State Institution "Institute of Pediatrics, Obstetrics and Gynecology of NAMS of Ukraine". Additionally, they completed their Master of Business Administration (M.B.A.) degree at Business School MIM Kyiv from 2015 to 2017.
This person is not in any offices
Acino
2 followers
Acino is a Swiss pharmaceutical company headquartered in Zurich, with a clear focus on high-growth markets. We deliver quality pharmaceuticals to promote affordable healthcare and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing. For more information: www.acino.swiss *** By engaging with Acino on LinkedIn (or any other Acino social media channel), you are agreeing to our Social Media Community Guidelines. If you do not agree to them, do not engage with Acino on social media. Please read our detailed community guidelines carefully here: https://acino.swiss/acino_social_media_community_guidelines_may2022 ***